Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

PeptiDream completes Y5.3bn IPO on the Toyko Stock Exchange

Executive Summary

PeptiDream Inc. has raised Y5.3bn ($52.4mm) in its IPO on the Mothers Market of the Tokyo Stock Exchange. The peptide drug developer sold 2.1mm shares (including the overallotment) for Y2.5k, the top end of its Y1.9-2.5k price range.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies